UK’s approval for Merck’s antiviral pill molnupiravir and Pfizer’s claim that its version cuts hospitalisation and death risk by 89% opens a new front against Covid after vaccines have succeeded in reducing disease severity. Merck...
from Times of India Opinion https://ift.tt/3o2vHd1
No comments:
Post a Comment